FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Lumipulse G CA19-9-N

K Number: K200997 · Decision May 14, 2020
Classifications
1
FEI Numbers
21
Registration Numbers
21
Same Product Code
10
Applicant Total
45
Review Days
28

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Lumipulse G CA19-9-N
K Number
K200997
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
866.6010
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Fujirebio Diagnostics,Inc.
Date Received
April 16, 2020
Decision Date
May 14, 2020
Product Code
NIG
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIG System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NIG), ordered by most recent decision date.

View all

Other Clearances by Fujirebio Diagnostics,Inc.

K Number Device Name
K250925 ADVIA Centaur Cytokeratin Fragment 21-1
K242706 Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio
DEN200072 Lumipulse G ß-Amyloid Ratio (1-42/1-40)
K192524 Lumipulse G CA15-3
K192380 ST AIA-PACK BNP
K190702 Lumipulse G whole PTH
K172713 Lumipulse G B•R•A•H•M•S PCT Immunoreaction Cartridges, Lumipulse G B•R•A•H•M•S PCT Calibrators set
K171103 Lumipulse G TSH-III Immunoreaction Cartridges
K163546 Lumipulse G Progesterone-N Calibrators
K163534 Lumipulse G FSH-N Calibrators
Search all 45 clearances from Fujirebio Diagnostics,Inc. →